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Abstract
Background: Bloodstream infections (BSIs) are associated with high morbidity and mortality worldwide. However
their aetiology, antimicrobial susceptibilities and associated outcomes differ between developed and developing
countries. Systematic data from Vietnam are scarce. Here we present aetiologic data on BSI in adults admitted to a
large tertiary referral hospital for infectious diseases in Hanoi, Vietnam.
Methods: A retrospective study was conducted at the National Hospital for Tropical Diseases between January 2011
and December 2013. Cases of BSI were determined from records in the microbiology department. Case records were
obtained where possible and clinical findings, treatment and outcome were recorded. BSI were classified as
community acquired if the blood sample was drawn ≤48 h after hospitalization or hospital acquired if >48 h.
Results: A total of 738 patients with BSI were included for microbiological analysis. The predominant pathogens were:
Klebsiella pneumoniae (17.5%), Escherichia coli (17.3%), Staphylococcus aureus (14.9%), Stenotrophomonas maltophilia
(9.6%) and Streptococcus suis (7.6%). The overall proportion of extended spectrum beta-lactamase (ESBL) production
among Enterobacteriaceae was 25.1% (67/267 isolates) and of methicillin-resistance in S. aureus (MRSA) 37% (40/108).
Clinical data was retrieved for 477 (64.6%) patients; median age was 48 years (IQR 36–60) with 27.7% female. The
overall case fatality rate was 28.9% and the highest case fatality was associated with Enterobacteriaceae BSI (34.7%)
which accounted for 61.6% of all BSI fatalities.
Conclusions: Enterobacteriaceae (predominantly K. pneumoniae and E. coli) are the most common cause of both
community and hospital acquired bloodstream infections in a tertiary referral clinic in northern Vietnam.
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Background
Bloodstream infections (BSIs) are an important cause of
sepsis-related morbidity and mortality worldwide [1]. A
systematic review of BSI burden in population based
studies estimated the annual numbers of BSI episodes
ranged from 575.462–677.389 in North America and
1,213,460–1,381,590 in Europe with the annual numbers
of BSI associated deaths were 79,466–93,655 and
57,750–276,318 respectively [2]. In developed setting,
the BSI and BSI associated septic shock still accounted
for 6% and 3% of all admission to ICUs with the in-
hospital mortality rates of 40% and 49% respectively [3].
Additionally, BSIs are associated with long-term risk of
mortality among survivors [4]. In a population based
study in Denmark, while the incidence of community
and hospital acquired BSIs annually decreased 3.7% and
4.2% respectively between 1998 to 2008, the incidence
rate of healthcare-associated bloodstream infection BSI
remained unchanged [4]. Data from low and middle in-
come countries (LMIC) on the causes of bloodstream
infection are limited [5], but crucial for enabling clini-
cians to direct antimicrobial therapy appropriately and
for the design of preventive measures. Useful lessons can
be learned from analysing the bacterial aetiology of BSIs
as most cases reflect severe illness and bacteria detected
are usually directly responsible for disease [6, 7]. The
causative agent will be affected by a number of factors,
particularly the focus of infection, comorbidities like im-
munodeficiency, chronic renal and liver disease, in
addition to socio-economic, climatic and other geo-
graphical factors [8]. The level of economic development
can also impact aetiology distribution through changing
exposure to environmental organisms associated with
urbanisation, changing farming and food consumption
practices, vaccination and comorbidities associated with
increased wealth and improved life expectancy [9].
Consequently, data from tropical emerging economies
are important to understanding and updating worldwide
trends of the aetiology of severe bacterial disease in the
tropics.
Vietnam is a low middle income country (LMIC), an
emerging economy and a hotspot for emerging infectious
diseases [10]. Levels of antibiotic resistance, an important
cause of treatment failure and subsequent mortality are also
high in Vietnam [11, 12]. In the Asian Network for
Surveillance of Resistant Pathogens with 11 participating
countries in 2001, Vietnam had a highest prevalence of
pneumococcal multidrug resistance (defined as resistance to
at least three classes of antibiotics) (71.4%) which much
higher than the second and third highest countries and ter-
ritories of Korea (54.8%) and Hong Kong (43.2%) [12]. In
another study in 20 hospitals in 5 Asia-Pacific countries, the
prevalence of carbapenem non-susceptible Gram-negative
pathogens was highest at 35.0% in Vietnam, in which the
prevalence of carbapenem non-susceptiblity among Pseudo-
monas aeruginosa, Enterobacteriaceae and Acinetobacter
baumannii were 46.7%, 5.6% and 89.5% respectively [11].
In-hospital mortality among patients with sepsis is
reduced by early initiation of adequate empiric
antibiotic therapy [13, 14] and strategies to promote
appropriate antibiotic use may help to prevent
antimicrobial resistance and optimise use of hospital
resources. However, the epidemiology of BSI in
Vietnamese adults and associated treatment outcomes
are not well studied. An understanding of BSI in
Vietnam, its resistance patterns and their impact on
patient’s outcomes is important to guide clinical
management and appropriate antibiotic use. This art-
icle reports on a retrospective analysis of three years
of BSI data at the National Hospital for Tropical
Diseases (NHTD), a large tertiary referral hospital for
infectious diseases in Hanoi, Vietnam.
Methods
Study design and data collection
This is a retrospective, cohort study of patients with
bacterial bloodstream infection (BSI) admitted to the
National Hospital for Tropical Diseases (NHTD) be-
tween January 1st, 2011 and December 31st, 2013.
NHTD is a 300-bed tertiary teaching hospital that
provides care to individuals suspected of an infectious
disease living within its catchment area. NHTD is
also a referral hospital assigned to all provincial
hospitals in the north of Vietnam for infectious dis-
eases that cannot be managed locally. As a result the
hospital receives patients both directly from the com-
munity and transferred from hospitals in the region.
The study included all positive blood cultures with
recognized bacterial pathogens among patients who
were hospitalized during the study period and add-
itional clinical information from a subgroup of pa-
tients whose patient records were available to the
investigators. A standard data collection form was
created to extract demographic & clinical data, micro-
biology and outcome information from routine patient
and microbiology records. Where patients had been
transferred from another hospital, the transfer letter
was examined for any record of antibiotic therapy
having been provided at the referring hospital.
Study definitions
A recognised bacterial pathogen identified as an organ-
ism which is not on the CDC’s National Healthcare
Safety Network (NHSN) common commensal list unless
there were 2 bottles from the same set were positive for
the same organism or a single positive bottle plus an evi-
dent focus of infection (abscess or valvular vegetation).
An episode of BSI was defined as the isolation of the
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organism(s) from one or more positive blood bottles
which were explainable by a common source of infection
and the time between two isolations was not interrupted
by an asymptomatic period. When the clinical informa-
tion was not available for judgment, the same organ-
ism(s) isolated within 48 h of another positive culture
was considered as the same episode [15].
A case of community-acquired BSI (CABSI) was de-
fined as a patient with a positive blood culture from a
blood sample drawn ≤48 h after hospitalization at any
health care facility (to ensure correct categorisation of
patients referred from another hospital) for the current
illness. Hospital-acquired BSI (HABSI) cases were de-
fined as patients with >48 h between admission at any
health care facility and the blood being drawn using the
referring letter when applicable [16, 17]. These data were
only available from patients whose clinical records were
available. Any BSI caused by Streptococcus suis or
Burkholderia pseudomallei, was classified as CABSI re-
gardless of when samples were taken with the assump-
tion that the acquisition of those infection due to
occupational exposure to pigs and environmental expos-
ure to contaminated environment are unlikely in the
hospital setting respectively [18, 19].
Blood for culture, approximately 5–10 mL of blood,
was collected in a single commercially sourced aerobic
bottle and incubated in an automated system (Bactec,
Becton Dickinson, USA) for five days (5–10 mL blood).
Bottles that flagged positive were Gram-stained, subcul-
tured and identified using standard microbiological tech-
niques, including VITEK and API testing (bioMérieux,
France). Antibiotic susceptibilities were performed using
CLSI guidelines with breakpoints from 2013 [20]. For S.
suis, the susceptibility was evaluated using CLSI break-
points for Streptococcus viridans group [21].
Fatal cases were defined as patients who died in
hospital or were discharged with diagnosis of brain
death and the expectation that they will die imminently
within hours or days (palliative discharge to die at home,
a common practice in Vietnam).
Data entry and statistical analysis
Data were entered in Epidata (EpiData Association, Odense,
Denmark) and analysed using SPSS 22.0.0 (IBM Co.,
Armonk, NY, USA). Standard descriptive statistics were
calculated for categorical (in percentage) and continuous
variables (median and interquartile, IQR). Bivariate analyses
were performed using Pearson’s chi-squared test or Fisher’s
Exact Test for categorical variables as appropriate. The pos-
sible selection bias was assessed by chi-square and t-test
analyses to compare gender and age differences between
those with and without clinical outcomes, respectively. Cox
proportional-hazards regression was used to identify vari-
ables that predict clinical outcomes. Cox’s proportional
hazards regression was performed to analyse factors associ-
ated with all-cause in-hospital mortality. BSI episodes of
polymicrobial infection and S. maltophilia infections were
excluded from regression analysis due to a small number
and an uncertain pathogenicity respectively. In cases where
there were multiple blood cultures positive, we only
included the first positive blood culture. All tests were
two-tailed and differences were considered statistically sig-
nificant at p values ≤0.05.
Results
Study population’s demographics
There were 894 positive blood cultures corresponding
to 835 BSI episodes in 825 patients recorded between
January 2011 and December 2013. Notes from 543/
825 (65.8%) patients could be retrieved to collect clin-
ical details of individual patients while 282 (34.2%)
were not available (Fig. 1). Sensitivity analysis of age
and gender showed no differences between cases with
and without clinical outcome (chi-square test,
p = 0.664 and t-test, p = 0.053 respectively). Among
collected records, sixty-six cases (12.2%, 66/543) were
subsequently classified by cultured organism as having
a pseudo-bacteremia due to contamination, including
16 cases with Burkholderia cepacia, 19 cases with
Alcaligenes species, 5 cases with Ralstonia pickettii
and 4 cases with Pseudomonas species (2 P. putida
and 2 P. stutzeri). There were 3 cases with Serratia
marcescens, 3 S. maltophilia, 1 K. pneumoniae and 1
E. coli which were classified as contaminants by
treating doctors at the time of results return, based
on patient’s survival and recovery without antibiotic
treatment for bacterial disease and with an alternative
possible viral diagnosis. Other contaminated cultures
were 3 cases with Ochrobactrum anthropi, 1 case with
Chryseobacterium indologenes, 1 case with Chryseomo-
nas luteola, 1 case with (non-diphtheroid) Corynebac-
terium spp., 1 case with Staphylococcus spp. and 7
cases with single culture of viridans group strepto-
cocci without an endovascular or other focus. As a
result, 477 cases were included for the clinical
analysis.
The median age of the group of 477 patients with
BSI was 48 years (IQR 36–60), 27.7% of patients were
female (132/477), 14 (10.6%) of whom were pregnant).
Common co-morbidities were chronic hepatitis or cirrho-
sis (14.3%, 68/477), diabetes mellitus (7.1%, 34/477) and
HIV infection (6.3%, 30/477) (Table 1).
In patients with CABSIs, 12.5% (50/400) had mul-
tiple positive blood cultures with either S. aureus or
K. pneumoniae. Whilst most patients with CABSI
were admitted directly from the community, 153/400
patients (38.3%) were transferred from other hospitals
within 48 h, with 62/153 patients (40.5%) recorded as
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having received antibiotics before admission to the
study hospital.
Aetiology of bloodstream infections
Analysis of microbiological dataset
During the 3 year period, a total of 738 BSI patients
were identified with 67.9% (501/738) with Gram-
negative bacteria isolated, 31% (229/738) Gram-positive
bacteria, and 1.1% (8/738) had two pathogens isolated in
the same culture bottle (n = 8). Enterobacteriaceae were
the most frequently isolated group of organisms among
patients with BSI (46.7%, 345/738) with the predominant
Enterobacteriaceae being K. pneumoniae (37.4%, 129/
345) and E. coli (37.1%, 128/345), followed by Salmon-
ella enterica (13.0% or 45/345) (Table 2).
Among Gram-positive isolates, S. aureus was the leading
pathogen (48% or 110/229), followed by S. suis (24.5% or
56/229) and other Streptococcus species (16.2% or 37/229).
Non- Enterobacteriaceae Gram-negative bacteria were
identified in 156 cases (21.1%), of which S. maltophilia
accounted for 45.5% (71/156).
The overall proportion of extended spectrum beta-
lactamases (ESBL) production among Enterobacteriaceae
was 25.1% (67/267 isolates, 78 missing result). Tables 3
and 4 display the antibiotic resistance of K. pneumoniae
and E. coli. The prevalence of ESBL production among
Fig. 1 Flowchart of BSI episodes and classification of BSI by location of acquisition. Classification based on the first isolate during hospitalization. HABSI:
Hospital-acquired bloodstream infection; CABSI: Community-acquired bloodstream infection. a Contaminant episodes included 22 episodes of B. cepacia,
25 episodes of Alcaligenes spp., 7 episodes of viridans group streptococci, 8 episodes of Ralstonia picketii, 6 episodes of Pseudomonas species (P. fluorescens,
P. putida and P. stutzeri) 4 episodes of Chryseobacterium spp., 3 episodes of S. maltophilia, 3 episodes of Serratia marcescens, 3 episodes of Ochrobactrum
antrhopi, 2 episodes of Sphingomonas paucimobilis, 1 episode of each E. coli, K. pneumonia, Corynebacterium spp. and Chryseomonas luteola
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E. coli isolates was significantly higher than in K. pneu-
moniae (45%, 50/111 vs 12.3%,15/122, p < 0.001).
Among Gram-positive bacteria, 97.4% (38/39) of S. suis
isolates were susceptible to penicillin with penicillin
MIC median of 0.032 (IQR 0.023–0.032) and only 1 case
was intermediate susceptible to penicillin with an MIC
of 0.23, though no confirmatory testing was performed.
Methicillin resistance was observed in 37% (40/108) of S.
aureus isolates and all 29 MRSA isolates tested with
vancomycin E-test were susceptible. Among 67 S. aureus
isolates tested for vancomycin by E-test, 62.7% (42/67)
of isolates had vancomycin MIC ≤1 μg/ml and 37.3%
(25/67) 1.5–2 μg/ml (Table 5).
Analysis of the clinical dataset
The proportions of CABSI and HABSI caused by
Enterobacteriaceae were not statistically different
(55.1%, 203/397 vs 58.4%, 45/77, p = 0.24), similar for
for non-enterobacteriaceae Gram-negative bacteria
(19.6%, 78/397 vs 27.3%, 21/77, p = 0.132). In con-
trast, Gram-positive bacteria were more frequently
identified in CABSI (29.2%, 116/397 vs 14.3%, 11/77,
p = 0.011) and Acinetobacter species were more com-
mon in HABSI (Table 2).
There was no difference in the proportion of ESBL
production in community versus hospital setting among
E. coli isolates (53.8%, 28/52 vs 55.6%, 5/9, p = 1.0). In
K. pneumoniae isolates, the proportion of ESBL produc-
tion were higher in HABSI (21.1%, 4/19 vs 6.1%, 5/82 vs,
p = 0.039). Compared with K. pneumoniae, E. coli iso-
lates were also more frequently resistant to aminoglyco-
sides (23.3%, 30/129 vs 13.0%, 17/131, p = 0.031) and
fluoroquinolones (31.8%, 41/128, vs 8.4%, 11/131,
p < 0.001).
K. pneumoniae isolates associated with HABSI more
frequently showed antibiotic resistance compared to
CABSI isolates, though statistical significance was only
reached for quinolones, while the pattern of resistance
among E. coli isolates did not differ between the hospital
and community (Tables 3 and 4). MRSA rates differed
between community (38.7%, 12/31) and hospital settings
(0/7), though this did not reach statistical significance
(p = 0.074). Case notes were not retrievable in 69/110
(62.7%) cases of S. aureus bacteremia.
Case fatality of bloodstream infection
Case fatality was assessed in the clinical dataset only.
The overall in-hospital case fatality rate among
patients was 138/477 (28.9%). Overall case fatality
rates among patients infected with Enterobacteriaceae,
non-Enterobacteriaceae and Gram-positive bacteria
were 34.7% (85/245), 29.3% (29/99) and 19% (24/126),
respectively (Fig. 2). There was no case of death
among patients with mix infections (0/7). Case fatality
rate in CABSI (27.5%, 110/400) was lower, but not
statistically different from HABSI (36.4%, 28/77)
(p = 0.131). In the most frequent isolates of E. coli,
K. pneumoniae, S. aureus, S. maltophilia and S. suis,
case-fatality rates were 35.6% (26/73), 35.5% (39/110),
26.8% (11/41), 17.0% (8/39) and 9.3% (4/39).
Multivariate Cox proportional hazard regression ana-
lysis was used to measure the effect of demographics, ac-
quisition of infection, co-morbidities, previous hospital
referring factors and bacterial species. Independent fac-
tors associated with case fatality were Enterobacteriaceae
Table 1 Characteristics of the clinical study population
Total Community acquired BSI Hospital acquired BSI
N = 477 N = 400 N = 77
n (%) n (%)
Age – median (IQR) 48 (36–60) 48 (36–60) 50 (32–60)
Female sex 132 (27.7%) 122 (30.6%) 10 (13%)
Any ICU admission during NHTD hospitalisation 245 (51.4%) 190 (47.5%) 55 (71.4%)
Any history of medical condition 142 (29.8%) 109 (27.3%) 33 (42.9%)
Liver disease 68 (14.3%) 54 (13.5%) 14 (18.2)
Diabetes 34 (7.1%) 25 (6.3%) 9 (11.7%)
Moderate or severe renal disease 9 (1.9%) 6 (1.5%) 3(3.9%)
HIV infection 30 (6.3%) 21 (5.3%) 9 (11.7%)
Other morbidity 10 (2.1%) 8 (2%) 2 (2.6%)
Long-term corticosteroid use 8 (1.7%) 7 (1.8%) 1 (1.3%)
Self-report alcoholism 67(14%) 56 (14%) 11 (14.3%)
Intravenous drug use 23 (4.8%) 17 (4.3%) 6 (7.8%)
aLiver disease was defined in a patient with chronic hepatitis and/or cirrhosis
bModerate or severe renal disease was defined in a patient with baseline creatinine >3 mg% (265 umol/l), dialysis or kidney transplantation
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and non-Enterobacteriaceae infection (HR 2.485, 95%CI
1.546–3.994 and HR 1.931, 95% CI 1.063–3.50, respect-
ively), co-morbidities (HR 1.467, 95% CI 1.017–2.114)
and referring from other hospital (HR 2.049, 95% CI
1.411–2.975) (Table 6).
Discussion
This retrospective study includes 3-years of complete
microbiological data on aetiology of BSI for 738 patients
and almost two thirds (64.6%, 477/738) of these patients
for clinical outcome analysis in a tertiary hospital in the
north of Vietnam.
Our study shows the important role of pathogenic
Gram-negative bacteria with a high proportion of
cephalosporin-resistant E. coli and K. pneumoniae iso-
lates and high prevalence of MRSA in CABSI. Our study
shows the high contribution of Enterobacteriaceae BSI
to mortality among adults admitted to our hospital in
Vietnam, with over 60% of deaths associated with this
group of bacteria. This study supports the observed shift
Table 2 Aetiology of bloodstream infections
Pathogen All patients Sampled clinical cases
Total CABSI HABSI pg
N = 738 N = 477 N = 400 N = 77
Enterobacteriaceae 345 (46.7%) 245 (51.4%) 200 (50%) 45 (58.4%) 0.213
Klebsiella pneumoniae 129 (17.5%) 110 (23.1%) 88 (22%) 22 (28.6%) 0.237d
Escherichia coli 128 (17.3%) 73 (15.3%) 64 (16%) 9 (11.7%) 0.391
Salmonella enterica 45 (6.1%) 30 (6.3%) 24 (6%) 6 (7.8%) 0.606
serovar Typhi 10 (1.4%) 4 (0.8%) 4 (1.00%) 0 1
non-typhi Salmonella 35 (4.7%) 26 (5.5%) 20 (5%) 6 (7.8%) 0.407
Serratia marcescens 16 (2.2%) 12 (2.5%) 9 (2.3%) 3 (3.9%) 0.421
Enterobacter species 16 (2.2%) 12 (2.5%) 8 (2.0%) 4 (5.2%) 0.112
Other Enterobacteriaceae speciesa 11 (1.5%) 8 (1.7%) 7 (1.8%) 1 (1.3%) 1
Non-Enterobacteriacae 156 (21.1%) 99 (20.8%) 78 (19.5%) 21 (27.3%) 0.127
Stenotrophomonas maltophilia 71 (9.6%) 47 (9.9%) 39 (9.8%) 8 (10.4%) 0.836
Aeromonas species 34 (4.6%) 14 (2.9%) 12 (3.0%) 2 (2.6%) 1
Burkholderia pseudomallei 15 (2.0%) 13 (2.7%) 13 (3.3%) 0
Pseudomonas aeruginosa 16 (2.2%) 13 (2.7%) 9 (2.3%) 4 (5.2%) 0.240
Acinetobacter speciesb 16 (2.2%) 10 (2.1%) 3 (0.8%) 7 (9.1%) <0.001
Other gram-negative bacteriac 4 (0.5%) 2 (0.4%) 2 (0.5%) 0 1
Gram-positive isolates 229 (31.0%) 126 (26.4%) 115 (28.8%) 11 (14.3%) 0.007
Staphylococcus aureus 110 (14.9%) 41 (8.6%) 34 (8.5%) 7 (9.1%) 0.826
Streptococcus suis 56 (7.6%) 43 (9.0%) 43 (10.8%) 0 -
Streptococcus species 37 (4.9%) 23 (4.8%) 21 (5.3%) 2 (2.6%) 0.559
S. pneumoniae 7 (0.9%) 5 (1.0%) 4 (1.0%) 1 (1.3%) 0.587
S. viridans groupd 21 (2.8%) 11 (2.3%)b 10 (2.5%) 1 (1.3%) 1
Beta-hemolytic streptococci 9 (1.2%) 7 (1.5%) 7 (1.8%) 0 0.604
Enterococcus species 14 (1.9%) 12 (2.5%) 10 (2.5%) 2 (2.6%) 1
Other gram-positive bacteriae 12 (1.6%) 7 (1.5%) 7 (1.8%) 0 0.604
Polymicrobialf 8 (1.1%) 7 (1.5%) 7 (1.8%) 0 0.604
aIncluding 3 cases with Klebsiella oxytoca, 3 cases with Proteus mirabilis, 2 cases with Escherichia hermannii, 1 case with Citrobacter freundii, 1 case with Morganella
morganii and 1 case with Vibrio vulnificus
bIncluding 12 cases with A. baumannii, 3 cases with A. lwoffii and 1 case with A. junii
cIncluding 1 case for Elizabethkingia meningosepticum, Haemophilus influenzae, Pasteurella multocida and Neisseria meningitidis,
dCases with viridans group infection had at least two positive blood culture or single positive blood culture plus vegetation on echocardiography
eIncluding 4 cases with Rhodococcus equi, 3 cases with Listeria monocytogenes, 2 cases with Aerococcus viridians, 2 cases with Listeria spp. and 1 case with
Listeria innocua
fIn 8 dual infection cases, 3 HIV infected cases had co-infection with Talaromyces marneffei and S. aureus, Escherichia hermannii or Salmonella group D; 1 case with
S. aureus and K. pneumoniae, 1 case with Enterococcus faecalis and viridans streptococci, 1 case with E. coli and K. pneumoniae and 1 case with S. aureus and E.
coli co-infection
gp values were calculated using Chi-square test or Fisher’s Exact test as appropriate
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within Enterobacteriaceae organisms from typhoidal and
non-typhoidal Salmonella to K. pneumoniae and E. coli,
the current leading causes of community acquired blood
stream infections.
In Vietnam, Salmonella enterica serovar Typhi was re-
ported to be the major cause of BSI, accounting for up
to 74% of isolates from blood in the 1990s but gradually
declined to 6% by 2008 [22]. With the recent emergence
of K. pneumoniae and E.coli, we observed the high
prevalence of extended spectrum Beta-lactamase (ESBL)
production in these pathogens, especially in the hospital
setting. In surveillance data from five Asia-Pacific
countries in 2010, Vietnam reported the highest rate of
ESBL positive Enterobacteriaceae isolates with an overall
prevalence of 55.1% and 80.1% in ICU patients [11]. The
high prevalence of antibiotic resistance in Vietnam may
be attributed to multiple factors, such as dispensing
practices in the community, lack of enforcement of
regulation, limited resources for microbiological
diagnostics, injudicious use of antibiotics in hospital,
community and agriculture and insufficient antibiotic
resistance surveillance and infection control [23].
In our study, ESBL production was detected among
6.1% K. pneumoniae from CABSI, which is consistent
with the low ESBL prevalence of 4.1% among K.
pneumoniae oropharyngeal carriers reported previously
from northern Vietnam [24]. The rate of ESBL-produc-
tion in E. coli(45%) was higher than in Thailand (CABSI,
11.8%) and Korea (31.3% in HABSI and 8.8% in CABSI)
and comparable to the prevalence of ESBL among E. coli
isolates in BSI in Cambodia (47.7%), [15, 17, 25]. The high
rate of ESBL carriage in E. coli from CABSI is deeply
worrying and likely reflects extensive overuse of oral ceph-
alosporins in the community, their use in agriculture or
other environmental sources [26, 27]. S. suis is a well-
recognized zoonotic pathogen associated with bacterial
meningitis and BSI among adults in Vietnam [10] and was
noted as an important Gram-positive pathogen cultured
from blood with high levels of susceptibility to penicillin.
Our study showed a higher case-fatality rate (110/400
or 27.5%) among community-acquired bacterial blood-
stream infections than the rate of 9% reported in a
review from 1990 to 2010 in south and southeast Asia
and the rate of 18.1% among patients with CABSI in a
meta-analysis in Africa from 1984 to 2006 [28, 29]. This
difference is likely related to the changes in spectrum of
aetiology with higher prevalence of Salmonella spp.
(53.2% of Enterobacteriaceae isolates) in the past [28],
the emergence of high levels of antibiotic resistance in
Vietnam and the tertiary referral nature of the study
hospital. The overall mortality in our study was slightly
higher than the overall mortality of 22.5% in Cambodia
Table 3 Resistance among K. pneumoniae from BSI
Resistance All isolates Sampled clinical cases
Total CABSI HABSI P value a
Any extended spectrum cephalosporin 19/133 (14.3%) 13/112 (11.6%) 8/90 (8.9%) 5/22 (22.7%) 0.128
ESBL production 15/122 (12.3%) 9/101 (8.9%) 5/82 (6.1%) 4/19 (21.1%) 0.062
Others 4/133 (3.0%) 4/112 (3.6%) 3/90 (3.3%) 1/22 (4.5%) 1
Any carbapenem 1/131 (0.8%) 1/109 (0.9%) 0/89 (0%) 1/20 (5%) 0.183
Any aminoglycoside 17/131 (13.0%) 13/109 (11.9%) 9/89 (10.1%) 4/20 (20%) 0.252
Any fluoroquinolone 11/131 (8.4%) 8/109 (7.3%) 4/89 (4.5%) 4/20 (20%) 0.036
Co-trimoxazole 24/124 (19.4%) 19/102 (18.6%) 14/84 (16.7%) 5/18 (27.8%) 0.318
ap values were calculated using Fisher’s Exact Test
Table 4 Resistance among E. coli from BSI
Resistance All isolates Sampled clinical cases
Total CABSI HABSI P valuea
Any extended spectrum cephalosporin 72/131 (55.0%) 45/74 (60.8%) 39/65 (60%) 6/9 (66.7%) 1
ESBL production 50/111 (45%) 33/61 (54.1%) 28/52 (53.8%) 5/9 (55.6%) 1
Others 22/131 (16.8%) 12/74 (16.2%) 11/65 (16.9%) 1/9 (11.1%) 1
Any carbapenem 1/130 (0.8%) 0/73 (0.0%) 0/64 (0.0%) 0/9 (0.0%) -
Any aminoglycoside 30/129 (23.3%) 15/73 (20.5%) 14/64 (21.9%) 1/9 (11.1%) 0.675
Any fluoroquinolone 41/129 (31.8%) 26/72 (36.1%) 22/63 (34.9%) 4/9 (44.4%) 0.714
Cotrimoxazole 62/90 (68.9%) 27/38 (71.1%) 24/33 (72.7%) 3/5 (60.0%) 0.615
Fosfomycin 1/52 (1.9%) 1/44 (2.3%) 1/38 (2.6%) 0/6 (0%) -
ap values were calculated using Fisher’s Exact Test
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where the epidemiology and pattern of resistance are
similar [15]. We reported a high mortality of 35.6%
among E. coli BSI, which is higher than mortality of
18.2% and 8% and in a large surveillance in England and
in a population-based study in Finland [30, 31]. It is not
clear about the reasons of the differences, but it may
relate to pneumonia focus, severity of infection, anti-
biotic susceptibilities and seasonal variation [31]. As
NHTD is a tertiary referral hospital, potentially more
severe cases or cases that have failed therapy elsewhere
may have been referred as compared to the hospitals
included in other studies, leading to higher resistance
and case fatality rates.
In North America and Europe, the nosocomial BSI
case fatality rate ranges from 12 to 32% [2]. Changes in
the aetiology of HABSI began in the 1960s–1970s in the
United States of America (US) with replacement of
Gram-negative by Gram-positive organisms, such that
65% of BSIs were S. aureus, the most common nosoco-
mial pathogen [32]. However, a Vietnamese population
based study indicated S. aureus nasopharyngeal carriage
proportion (33.8%, CI 29.4–38.8) was higher than in
European regions and the States [33], and S. aureus BSI
is still mainly community-acquired in Vietnam [34]. In
Vietnam the proportion of BSI attributable to S. aureus
did not change during the 15-years from 1994 to 2008
[22]. Gram-negative bacilli are still recognized as the
most frequent nosocomial isolates in developing
countries [35]. In a multicenter surveillance study in
Thailand, Gram-negative bacteria accounted for 67.6%
of HABSI, of which Acinetobacter spp. (16.2%) was
detected most frequently, followed by K. pneumoniae
(13.9%) and S. aureus (13.9%) and the in-hospital
mortality was 26.6% [36]. The overall case fatality rate of
36.4% among HABSI in our study population was higher
than seen in North America and Europe. This may be
related to higher levels of antibiotic resistance,
differences in the availability of resources or the nature
of admissions to NHTD, as described earlier.
We observed a predominance of males among patients
with BSI (72.3%). This phenomenon was similar as in
the cause of death reports in another tertiary hospital in
the north of Vietnam where the top three of causes of
death were septic shock, intracerebral haemorrhage and
pneumonia. The proportion of males in this report was
higher than females (1577/2340 or 67.4%) [37].
Among common isolates causing BSI, we reported the
high prevalence of S. maltophilia (9.6%. 71/738) which is
only rarely considered a pathogen, particularly from the
community [32]. Whilst S. maltophilia was described as
a recognised cause of CABSI among patients with
Table 6 Cox proportional hazards model of factors associated
with all-cause in-hospital case fatality among patients with
bloodstream infections due to a single organism in clinical
dataset
Variable Hazard ratio
(95% CI)a
P-valueb
Gender (male/female) 1.347 (.857–2.115) 0.196
Age (1-yr. increment) 1.008 (0.998–1.01) 0.118
Aetiology of BSI (gram-positive
bacterial infection as reference)
Enterobacteriaceae infections 2.485 (1.546–3.994) <0.001
Non Enterobacteriaceae
Gram-negative infections
1.931 (1.063–3.50) 0.031
Acquisition of infection
(CABSI as reference)
1.006 (0.633–0.399) 0.053
Any co-morbidities 1.467 (1.017–2.114) 0.040
Referring from another hospital 2.049 (1.411–2.975) <0.001
aCases with S. maltophilia infection were excluded from analysis
bHazard ratios and P-values were calculated using Cox proportional
hazards model
Table 5 Resistance among S. aureus from BSI
Susceptibility All isolates Sampled clinical cases
Total CABSI HABSI P value a
Methicillin (MRSA) 40/108 (37%) 12/38 (31.6%) 12/31 (38.7%) 0/7 (0%) 0.074
Erythromycin 39/72 (54.2%) 11/23 (47.8%) 10/18 (55.6%) 1/5 (20%) 0.317
Clindamycin 56/109 (51.4%) 21/40 (52.5%) 18/23 (54.5%) 3/7 (42.9%) 0.689
Chloramphenicol 35/105 (33.3%) 14/38 (36.8%) 11/31 (35.5%) 3/7 (42.9%) 1
Gentamicin 18/76 (23.7%) 9/26 (34.6%) 7/21 (33.3%) 2/5 (40%) 1
Ciprofloxacin 19/99 (19.2%) 7/33 (21.2%) 6/28 (21.4%) 1/5(20%) 1
Levofloxacin 18/103 (17.5%) 9/40 (22.5%) 6/13 (18.2%) 3/7 (42.9%) 0.316
Co-trimoxazole 8/62 (12.9%) 5/28(17.9%) 4/21 (19%) 1/7 (14.3%) 1
Rifampicin 10/95 (10.5%) 6/33 (18.2%) 5/27 (18.5%) 1/6 (16.7%) 1
Vancomycinb 0/63 (0%) - - - -
ap values were calculated using Fisher’s Exact Test
bThe vancomycin susceptibility and the MRSA rate were defined by Minimum Inhibitory Concentrations (MICs) using E-test
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comorbidities in a systematic review [38] and a recent
publication from Taiwan [39], another publication de-
scribes contamination of blood culture bottles with S.
maltophilia due to growth of the bacteria in disinfectant
[40]. Furthermore, we have observed pseudoepidemics
of S. maltophilia in this hospital (multiple patients from
geographically disparate sites with different infection
syndromes, newly admitted on the same ward with S.
maltophilia cultured from blood at the same time). The
retrospective nature of this study makes it difficult to
define whether these isolates were true pathogens or
represented contamination. Given how frequently this
organism was isolated, further prospective investigation
is required.
Our study has some important limitations. Firstly,
NHTD is a tertiary referral hospital and specializes in
infectious diseases. Therefore, the pattern of aetiology,
resistance and spectrum of clinical disease is different
from that seen in district and provincial level hospitals
due to referral of certain syndromes, more severe and
non-responsive cases.
Secondly, during the study period, only a single blood
culture was routine collected and as a cost saving
technique, routine laboratory practice was that cultures
showing obvious contamination (multiple organisms,
skin flora etc.) were discarded before full work up
without recording this finding. This will have lowered
estimations of blood culture sensitivity, which can be
improved with more blood cultures and higher volumes
of blood [41, 42]. Additionally, although the isolates of
Enterobacteriaceae members are almost always
interpreted as true bloodstream infections, single blood
culture practice may underestimate the roles of fastidi-
ous pathogens in the era of increased catheters and
prosthetic devices-related bloodstream infections [43].
In our study hospital acquired BSI was defined as cases
with positive blood culture after any hospitalization for
more than 48 h. Thus, patients who in reality had CABSI
but with persistent bacteraemia, who were transferred
after an inpatient stay at another hospital may have been
misclassified as HABSI. The significance and role of
certain bacteria, such as S. maltophilia or Aeromonas spe-
cies, which have been associated with both pseudo-
bacteraemia and real infection was not easy to establish
because of a lack of repeat sampling in most of patients
and the retrospective nature of the study. Lastly, clinical
outcome analysis was only applied for 64.6% (477/738) of
patients during the study period because the remaining
patient’s notes could not be retrieved. This has resulted in
significant gaps in the data and may have introduced bias
if the sample was not random.
Conclusions
Gram-negative bacteria are the most common cause of
both community and hospital acquired blood stream
infection in adults presenting to our tertiary referral hos-
pital, with high associated mortality. The extended
spectrum beta-lactamase (ESBL)-producing Enterobacte-
riaceae are prevalent in both community and health care
setting. Our findings further support the need, as
described in the GARP situation analysis [44] and the
2013 Vietnamese National Action Plan for AMR [45],
for establishment of a comprehensive microbiological
and antibiotic susceptibility surveillance system in
Vietnam, with representation of the different levels of
healthcare and to inform treatment guidelines and other
public health measures.
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